Teva Pharmaceuticals
TEVA
TEVA
779 hedge funds and large institutions have $26B invested in Teva Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 77 funds opening new positions, 256 increasing their positions, 300 reducing their positions, and 66 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $24.9B → $26B (+$1.1B)
15% less repeat investments, than reductions
Existing positions increased: 256 | Existing positions reduced: 300
16% less funds holding in top 10
Funds holding in top 10: 58 → 49 (-9)
Holders
779
Holding in Top 10
49
Calls
$1.58B
Puts
$579M
Top Buyers
| 1 | +$667M | |
| 2 | +$584M | |
| 3 | +$539M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$299M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$262M |
Top Sellers
| 1 | -$961M | |
| 2 | -$550M | |
| 3 | -$159M | |
| 4 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$129M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$115M |